Immunocore Holdings (IMCR) Shares Outstanding (Weighted Average) (2019 - 2026)

Immunocore Holdings has disclosed Shares Outstanding (Weighted Average) across 8 years of filings, most recently posting $50.8 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $50.8 million, up 1.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.8 million (up 1.33% YoY), and the FY2025 annual result was $50.3 million, up 0.71% from the prior year.
• Shares Outstanding (Weighted Average) came in at $50.8 million for Q1 2026 at Immunocore Holdings, up from $50.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $53.6 million in Q4 2022 to a low of $48.2 million in Q1 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $50.0 million (2024), against an average of $50.0 million.
• Across the five-year window, Shares Outstanding (Weighted Average) decreased 8.82% in 2023 and climbed 3.51% in 2024, its largest moves.
• Immunocore Holdings' Shares Outstanding (Weighted Average) stood at $53.6 million in 2022, then fell by 8.82% to $48.9 million in 2023, then rose by 2.25% to $50.0 million in 2024, then grew by 0.71% to $50.3 million in 2025, then increased by 0.81% to $50.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $50.8 million (Q1 2026), $50.3 million (Q4 2025), and $50.3 million (Q3 2025), per Business Quant data.